- Home
- KRMD vs OXSQ Comparison
KRMD vs OXSQ Comparison
Compare KRMD & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- OXSQ
- Stock Information
- Founded
- KRMD 1980
- OXSQ 2003
- Country
- KRMD United States
- OXSQ United States
- Employees
- KRMD N/A
- OXSQ N/A
- Industry
- KRMD Medical/Dental Instruments
- OXSQ Blank Checks
- Sector
- KRMD Health Care
- OXSQ Finance
- Exchange
- KRMD Nasdaq
- OXSQ Nasdaq
- Market Cap
- KRMD 134.3M
- OXSQ 164.9M
- IPO Year
- KRMD N/A
- OXSQ N/A
- Fundamental
- Price
- KRMD $3.62
- OXSQ $2.26
- Analyst Decision
- KRMD Strong Buy
- OXSQ
- Analyst Count
- KRMD 4
- OXSQ 0
- Target Price
- KRMD $4.63
- OXSQ N/A
- AVG Volume (30 Days)
- KRMD 456.1K
- OXSQ 533.4K
- Earning Date
- KRMD 08-06-2025
- OXSQ 08-12-2025
- Dividend Yield
- KRMD N/A
- OXSQ 18.58%
- EPS Growth
- KRMD N/A
- OXSQ N/A
- EPS
- KRMD N/A
- OXSQ N/A
- Revenue
- KRMD $35,083,740.00
- OXSQ $42,166,831.00
- Revenue This Year
- KRMD $18.16
- OXSQ N/A
- Revenue Next Year
- KRMD $14.60
- OXSQ N/A
- P/E Ratio
- KRMD N/A
- OXSQ N/A
- Revenue Growth
- KRMD 19.65
- OXSQ N/A
- 52 Week Low
- KRMD $1.86
- OXSQ $2.14
- 52 Week High
- KRMD $5.05
- OXSQ $3.10
- Technical
- Relative Strength Index (RSI)
- KRMD 66.17
- OXSQ 45.27
- Support Level
- KRMD $3.45
- OXSQ $2.14
- Resistance Level
- KRMD $3.77
- OXSQ $2.33
- Average True Range (ATR)
- KRMD 0.22
- OXSQ 0.03
- MACD
- KRMD 0.02
- OXSQ 0.01
- Stochastic Oscillator
- KRMD 75.81
- OXSQ 66.67
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.